Metsera, Inc. MTSR
We take great care to ensure that the data presented and summarized in this overview for Metsera, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MTSR
Top Purchases
Top Sells
About MTSR
Insider Transactions at MTSR
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 13
2025
|
Fmr LLC |
SELL
Other acquisition or disposition
|
Indirect |
2,233,460
-100.0%
|
-
|
|
Nov 13
2025
|
Arch Venture Partners Xii, LLC Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
26,816,808
-100.0%
|
-
|
|
Nov 13
2025
|
Matthew Lang CHIEF LEGAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,500
-100.0%
|
-
|
|
Nov 13
2025
|
Paul L Berns |
SELL
Sale (or disposition) back to the issuer
|
Direct |
961,590
-100.0%
|
-
|
|
Nov 13
2025
|
Paul L Berns |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
15,837,362
-100.0%
|
-
|
|
Nov 13
2025
|
Steven Marso CHIEF MEDICAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,000
-100.0%
|
-
|
|
Nov 13
2025
|
Population Health Partners Gp, LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
12,639,787
-100.0%
|
-
|
|
Nov 13
2025
|
Population Health Partners Gp, LLC |
SELL
Sale (or disposition) back to the issuer
|
Direct |
127,675
-100.0%
|
-
|
|
Nov 13
2025
|
Kristina Burow |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
51,411,394
-100.0%
|
-
|
|
Nov 13
2025
|
Kristina Burow |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,688
-100.0%
|
-
|
|
Nov 13
2025
|
Christopher Whitten Bernard |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
12,767,462
-100.0%
|
-
|
|
Nov 13
2025
|
Christopher Whitten Bernard |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,250
-100.0%
|
-
|
|
Nov 13
2025
|
Clive Meanwell EXECUTIVE CHAIRMAN |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
12,767,462
-100.0%
|
-
|
|
Nov 13
2025
|
Clive Meanwell EXECUTIVE CHAIRMAN |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,375
-100.0%
|
-
|
|
Nov 13
2025
|
Christopher Visioli CHIEF FINANCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,250
-100.0%
|
-
|
|
Nov 13
2025
|
Brian Hubbard CHIEF SCIENTIFIC OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,000
-100.0%
|
-
|
|
Nov 13
2025
|
Jon P Stonehouse |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,688
-100.0%
|
-
|
|
Nov 13
2025
|
Joshua Pinto |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,688
-100.0%
|
-
|
|
Nov 11
2025
|
Validae Health, L.P. |
SELL
Other acquisition or disposition
|
Direct |
12,767,462
-100.0%
|
-
|
|
Nov 10
2025
|
Fmr LLC |
SELL
Bona fide gift
|
Indirect |
860,722
-27.84%
|
-
|
Last 12 Months Summary
Buy / Acquisition
73.4M
Shares
From
9
Insiders
| Conversion of derivative security | 61M shares |
|---|---|
| Other acquisition or disposition | 7.18M shares |
| Open market or private purchase | 5.23M shares |
Sell / Disposition
158M
Shares
From
16
Insiders
| Bona fide gift | 1.49M shares |
|---|---|
| Other acquisition or disposition | 23M shares |
| Open market or private sale | 461 shares |
| Sale (or disposition) back to the issuer | 133M shares |